Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection
Wolszczak-Biedrzycka, B.; Bieńkowska, A.; Zaborowska, J.E.; Smolińska-Fijołek, E.; Biedrzycki, G.; Dorf, J. Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection. Vaccines 2022, 10, 741. https://doi.org/10.3390/vaccines10050741
Wolszczak-Biedrzycka B, Bieńkowska A, Zaborowska JE, Smolińska-Fijołek E, Biedrzycki G, Dorf J. Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection. Vaccines. 2022; 10(5):741. https://doi.org/10.3390/vaccines10050741
Chicago/Turabian StyleWolszczak-Biedrzycka, Blanka, Anna Bieńkowska, Joanna E. Zaborowska, Elwira Smolińska-Fijołek, Grzegorz Biedrzycki, and Justyna Dorf. 2022. "Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection" Vaccines 10, no. 5: 741. https://doi.org/10.3390/vaccines10050741